Israeli experts are heading to Denmark to create one of the country’s largest medicinal cannabis production facilities near the city of Møeldrup.
Sababa Sciences Inc. will manage the construction of a 49,600 sq. ft. cultivation unit on behalf of International Cannabis Corp (CSE: WORLD). It has a similar agreement in place in Poland, where it is using its expertise to build a facility for International Cannabis as the producer seeks to expand across Europe.
Medicinal cannabis has been legal in Israel since the early 1990s and it is a lot more advanced than the European countries that are currently rolling out a licensed trade. Sababa’s subsidiary, Relief Aps, will send its team to Denmark to begin construction of the GMP-certified unit in the second quarter of 2019.
Sababa will also manage a design and engineering firm called Azrom as it creates a cutting-edge greenhouse at the facility in western Denmark. The Israeli company’s agronomy team will also be in Møeldrup to manage a strain catalogue in the genetics room there.
They chose western Denmark due to its highly educated workforce and robust agricultural industry. Denmark is one of the leading lights in the European medicinal cannabis industry, and the end goal is to sell flower and derivatives across the country through a retail pharmacy network.
The Danish government pays for all marijuana prescriptions its citizens receive for medicinal cannabis, making it a potentially lucrative market. It is also close to Germany, Europe’s largest cannabis market, allowing for direct imports of CBD.
International Cannabis has increased its footprint in Denmark and it now controls a 100-acre property near Moeldrup. It expects to complete the design work by the end of the year and Sababa will begin putting the infrastructure in place in January.
“Through its partnerships with Sababa and Azrom, the company is working with world-renowned experts in greenhouse engineering, manufacturing and construction,” said International Cannabis chief executive Eugene Beukman. He called it a “premier European cannabis asset” and declared that the team has laid the groundwork for a very successful 2019.
ICC now has cultivation operations in place in Colombia, Denmark, Poland, Greece, Portugal, South Africa, and the Kingdom of Lesotho.
The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Grizzle hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.